期刊文献+

低抗原含量百日咳疫苗效力评价研究 被引量:2

Assessment of potency of low-antigen-content of pertussis vaccine
暂未订购
导出
摘要 目的应用改良小鼠脑腔攻击试验(MICA)检测评价低抗原含量百日咳疫苗效力。方法通过中检院和国外实验室平行应用改良小鼠脑腔攻击试验进行不同稀释度相同批次低抗原含量百日咳疫苗的效力,并应用统计软件分析。结果中检院与国外实验室所获得低抗原含量百日咳疫苗的MICA试验效力结果数据均较低(<1.1IU/mL),中检院计算出的效价均在国外实验室分析得出效价的95%可信区间内。结论 MICA方法可应用于低抗原含量百日咳疫苗效力检测分析,该研究为进一步确定中国低抗原含量百日咳疫苗的MICA试验检定标准奠定了基础。 Objective To evaluate the potency of low-antigen-content of pertussis vaccine by modified intracerebral challenge po- tency. Methods The same lots of pertussis vaccines at different dilutions were detected in parallel using the MICA in NIFDC,China and foreign laboratory. All the data were analyzed using statistical software. Results The results from NIFDC and foreign laborato- ry showed that the MICA potency units of low-antigen-eontent pertussis vaccine detected was low(〈l. 1 IU/mL),and the potency units from NIFDC were in the 95% confidence interval of the results from foreign lahoratory analysis. Conclusion MICA can he applied to assess the potency of low-antigen-content pertussis. These results will provide the basis of definition of MICA potency specification of low-antigen-content pertussis vaccine in China.
出处 《国际检验医学杂志》 CAS 2012年第21期2561-2562,2564,共3页 International Journal of Laboratory Medicine
基金 国家高技术研究发展("863"计划)资助项目(2012AA02A402)
关键词 百日咳菌苗 效力 改良小鼠脑腔攻击试验 pertussis vaccine potency modified intracerebral challenge potency
  • 相关文献

参考文献7

  • 1Sato Y,Sato H. Development of acellular pertussis vaccines[J].Biologicals,1999,(02):61.
  • 2Corbel MJ,Xing DK. Toxicity and potency evaluation of pertussis vaccines[J].Expert Review of Vaccines,2004,(01):89-101.
  • 3Gaines-Das R,Horiuchi Y,Zhang SM. Modified intra-cerebral challenge assay for acellular pertussis vaccines:comparisons among whole cell and acellular vaccines[J].Vaccine,2009,(49):6824-6832.
  • 4国家药典委员会.中国药典(三部)[S]北京:中国医药科技出版社,201062-66.
  • 5王晓娟,廖雪雁,李河民.百日咳疫苗加强免疫的探讨[J].中国疫苗和免疫,2009,15(5):477-479. 被引量:6
  • 6持续性咳嗽儿童百日咳临床多中心调查研究[J].中华儿科杂志,2010,48(10):748-752. 被引量:30
  • 7Scott LJ. Tdap5 vaccine (Covaxis):a review of its use as a single-booster immunization for the prevention of tetanus,diphtheria,and pertussis in children (aged 4 years),adolescents,and adults[J].BioDrugs,2010,(06):387-406.

二级参考文献40

共引文献34

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部